Honeywell Automation expects strong order flows and capex expenditure to rise

We see a lot of growth from the pharma and life science sector. The gas infrastructure is seeing increased traction and we are focussed on that area as well, said Gaikwad.

“The markets are looking better, people have better sentiments in terms of investments in the sectors that we are operating. We do not see a dry pipeline. We see that people are very inquisitive about the new technology; it’s not just about providing the same old solution pre-pandemic era, there is a renewed interest in terms of how we can bring more productivity, automation, digitization so that there is a new way of investing in rupees/dollars into the manufacturing for a much higher world-scale productivity,” he said.

For full management commentary, watch the video